These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38843485)

  • 1. Letter to the Editor: Baseline viral load in chronic hepatitis B may be clinically significant but must be interpreted with caution.
    Tang T; Li LQ; Wang ZD
    Hepatology; 2024 Nov; 80(5):E85. PubMed ID: 38843485
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
    Liao X; Fan R
    Hepatology; 2024 Sep; 80(3):E46-E47. PubMed ID: 38919029
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
    Luo C
    Hepatology; 2024 Oct; 80(4):E57. PubMed ID: 38743007
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter to the Editor: Chronic hepatitis B baseline viral load and on-treatment liver cancer risk-A multinational cohort study of HBeAg-positive patients.
    He T; Zhang D
    Hepatology; 2024 Aug; 80(2):E26-E27. PubMed ID: 38607724
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients.
    Choi WM; Yip TC; Kim WR; Yee LJ; Brooks-Rooney C; Curteis T; Clark LJ; Jafry Z; Chen CH; Chen CY; Huang YH; Jin YJ; Jun DW; Kim JW; Park NH; Peng CY; Shin HP; Shin JW; Yang YH; Wong GL; Lim YS
    Hepatology; 2024 Aug; 80(2):428-439. PubMed ID: 38436992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correspondence to letter to the editor on "Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B".
    Kim GA; Choi SW; Lim YS
    Clin Mol Hepatol; 2024 Aug; ():. PubMed ID: 39103999
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
    Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
    Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
    Choi WM; Kim GA; Choi J; Choi GH; Lee YB; Sinn DH; Lim YS
    Gut; 2024 Mar; 73(4):649-658. PubMed ID: 37813567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Viral Load and On-treatment Hepatocellular Carcinoma Risk in Chronic Hepatitis B: A Multinational Cohort Study.
    Choi WM; Yip TC; Wong GL; Kim WR; Yee LJ; Brooks-Rooney C; Curteis T; Clark LJ; Jafry Z; Chen CH; Chen CY; Huang YH; Jin YJ; Jun DW; Kim JW; Park NH; Peng CY; Shin HP; Shin JW; Yang YH; Lim YS
    Clin Gastroenterol Hepatol; 2024 Aug; ():. PubMed ID: 39181430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter to the Editor: Should We Really Take Anti-Viral Therapy into Account in Chronic Hepatitis B Patients with Normal Liver Function?
    Khosravi MH; Alavian SM
    J Korean Med Sci; 2016 May; 31(5):824. PubMed ID: 27134509
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between hepatitis B DNA viral load in the liver and its histology in patients with chronic hepatitis B.
    Biazar T; Yahyapour Y; Hasanjani Roushan MR; Rajabnia R; Sadeghi M; Taheri H; Ranaei M; Bayani M
    Caspian J Intern Med; 2015; 6(4):209-12. PubMed ID: 26644894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the Editor: Benefits of stopping therapy in patients with cirrhotic hepatitis B, true effect or residual confounding?
    Dongelmans EJ; Sonneveld MJ; Janssen HLA
    Hepatology; 2024 Mar; 79(3):E95-E96. PubMed ID: 37862458
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter to the Editor: Cautious interpretation of the association between finite treatment and better prognosis in initially HBeAg-negative hepatitis B patients with cirrhosis.
    Deng R; Wang Z; Liu Y; Sun J
    Hepatology; 2024 Apr; 79(4):E107-E108. PubMed ID: 37906598
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.
    Huang R; Wang J; Yan X; Xia J; Wu C
    Aliment Pharmacol Ther; 2019 Sep; 50(5):618-619. PubMed ID: 31414546
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of carriers of hepatitis B virus from a tertiary referral hospital: does the viral load change during the natural course of infection?
    Aakanksha ; Asim M; Sharma PK; Das BC; Kar P
    J Med Virol; 2011 Jul; 83(7):1151-8. PubMed ID: 21520137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression.
    Huang CJ; Wu CF; Lan CY; Sung FY; Lin CL; Liu CJ; Liu HF; Yu MW
    PLoS One; 2013; 8(7):e70169. PubMed ID: 23936156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load.
    Tseng TC; Liu CJ; Yang WT; Hsu CY; Hong CM; Su TH; Tsai CH; Chen CL; Yang HC; Liu CH; Chen HH; Chen PJ; Kao JH
    Aliment Pharmacol Ther; 2021 Apr; 53(8):908-918. PubMed ID: 33465271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B.
    Choi WM; Kim GA; Choi J; Han S; Lim YS
    J Clin Invest; 2022 May; 132(10):. PubMed ID: 35358094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Authors' reply.
    Choi GH; Lim YS
    Aliment Pharmacol Ther; 2019 Sep; 50(5):619-620. PubMed ID: 31414529
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs.
    Cai S; Li Z; Yu T; Xia M; Peng J
    Infect Drug Resist; 2018; 11():469-477. PubMed ID: 29662321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.